Industry Perspective on the Medical Risk of Visible Particles in Injectable Drug Products
Link to article by S. Bukofzer, et al. in the PDA Journal of Pharmaceutical Science and Technology, 69, 123-139 (2015)
This review article considers in detail the risks caused by the presence of visible and sub-visible particles in parenteral drug products.
Please Signup/Login to see the full article.Click here